Immunization therapies in the prevention of diabetes

Journal of Autoimmunity

Volumn 10, Issue 3, 1997, Pages 287-292

  Ramiya, Vijayakumar K ^a   Lan, Michael S ^a   Wasserfall, Clive H ^a   Notkins, Abner L ^a   MacLaren, Noel K ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b The Research Institute for Children at Children's Hospital New Orleans   (United States)

Author keywords

Immunization therapy; Immunologically mediated diabetes; Islet autoantigens; NOD mice

Indexed keywords

AUTOANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; CLONAL ANERGY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RECEPTOR AFFINITY; T LYMPHOCYTE ACTIVATION;

EID: 0031171301     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0127     Document Type: Conference Paper

References (24)

1. Lan M.S., Wasserfall C.W., Maclaren N.K., Notkins A.L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 93:1996;6367-6370.
2. Lan M.S., Lu J., Goto Y., Notkins A.L. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13:1994;505-514.
3. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting T.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T cell self tolerance to glutamate decarboxylase is a key event in the pathogenesis of murine insulin-dependent diabetes. Nature. 366:1993;69-71.
4. Muir A., Peck A., Clare-Salzler M., Song Y.-H., Cornelius J., Luchetta R., Krischer J., Maclaren N.K. Insulin immunization of NOD mice induces a protective insulitis characterized by diminished intra-islet interferon-gamma transcription. J. Clin. Invest. 95:1995;628-634.
5. Weiner H.L., Mackin G.A., Matsui M., Orav E.J., Khoury S.J., Dawson D.M., Hafler D.A. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 259:1993;1321-1324.
6. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trentham D.E., Hafler D.A. Oral tolerance: immunological mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:1994;809-837.
7. Husby S., Mestecky J., Moldovenanu Z., Holland S., Elson C.O. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152:1994;4663-4670.
8. Daniel D., Wegmann D.R. Intranasal administrations of insulin peptide B: 9-23 protects NOD mice from diabetes. Ann. N.Y. Acad. Sci. 778:1996;371-372.
9. Daniel D., Wegmann D.R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administrations of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA. 93:1996;256-260.
10. Tian J., Atkinson M.A., Clare-Salzler M., Herschenfeld A., Forsthuber T., Lehmann P.V., Kaufman D.L. Nasal administration of glutamic acid decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1996;1561-1567.
11. 67. Diabetes. 43:1994;1494-1499.
12. Gottlieb D.I., Chang Y.C., Schwob J.E. Monoclonal antibodies to glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA. 83:1986;8808-8812.
13. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50:1988;163-170.
15. Ramiya V.K., Shang X.Z., Pharis P.G., Wasserfall C.W., Stabler V.S., Muir A.B., Schatz D.A., Maclaren N.K. Antigen based therapies to prevent diabetes in NOD mice. J. Autoimmun. 9:1996;349-356.
16. 65. J. Autoimmun. 7:1994;865-872.
17. Harrison L.C., Honeyman M.C., Deaizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 341:1993;1365-1369.
18. Atkinson M.A., Maclaren N.K. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 92:1993;1608-1616.
19. Wegmann D., Norbury-Glaser M., Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24:1994;1853-1857.
20. Lu J., Li Q., Xie H., Chen Z.J., Borovitzkaya A.E., Maclaren N.K., Notkins A.L., Lan M.S. Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37 kDa tryptic fragment. Proc. Natl. Acad. Sci. USA. 93:1996;2307-2311.
21. Harada M., Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia. 27:1984;604-606.
22. Rothe H., Faust A., Schade V., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. Cyclophosphamide treatment of female nonobese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not interleukin-4. Diabetologia. 37:1994;1154-1158.
23. Nicoletti F., Zaccone P., Di-Marco R., Margo G., Grasso B., Marrone S., Santoni A., Tempera G., Meroni P.L., Bendtzan K. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology. 85:1995;645-650.
24. Parish N.M., Hutchings P.R., Waldmann H., Cooke A. Tolerance to IDDM induced by CD4 antibodies in nonobese diabetic mice is reversed by cyclophosphamide. Diabetes. 42:1993;1601-1605.